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Abstract
Approximately two million people in the United States (US) are infected annually by
organisms that have developed resistance to one or more of the antimicrobials designed
to eradicate them. The highest-ranking category of illness for which antibiotics are most
commonly overprescribed is respiratory infections (CDC, 2014a). The purpose of this
project was to explore current antimicrobial prescribing trends for respiratory infections
at an urgent care facility. The ACE Star Model of Knowledge Transformation (Stevens,
2004) was utilized to serve as a guide in conducting this research study. Utilizing the
detailed guidelines and treatment criteria for respiratory infections developed by the
American College of Chest Physicians, a determination regarding the appropriateness of
treatment was made. In this study, the rate of overprescribing at the study site was found
to be approximately 22.66% as compared to the national average of 50% (CDC, 2013).
Calculating the current prescribing trends and overprescribing rates is the first step in
acknowledging the issue within this particular setting. Much more progress needs to be
made to address methods and strategies for resolution including the adaptation of a
modified antimicrobial stewardship applicable to ambulatory/urgent care settings
Regardless of how the resolution to this worldwide problem will come about, it will not
happen without multi-disciplinary cooperation. Advanced practice nurses are in a unique
position to be able to act as leaders and educators regarding this issue.
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Respiratory Infections and Antimicrobial Prescribing: How Well are the
Guidelines Being Adhered to?
Background and Statement of the Problem
In a digital press kit released by the Centers for Disease Control and Prevention

(CDC, 2012), Associate Director for Healthcare Associated Infection Prevention
Programs, Arjun Srinivasan MD, stated that we are nearing maximum potential in our
ability to treat infectious diseases and that organisms are evolving faster than the
antibiotics manufactured to treat them. While the number of lives saved by antibiotics is
undoubtedly staggering, so also, is the steadily increasing number of lives lost due to the
inefficacy, in part related to overuse of those same drugs. Decades of poor prescribing
practices have paved the way for the rapid upsurge of drug sensitivities, allergic
reactions, resistant infections and potentially fatal cases of diarrhea (CDC, 2014a).
Approximately two million people in the United States (US) are infected annually
by organisms that have developed resistance to one or more of the antimicrobials
designed to eradicate them. Roughly 23,000 of those people will succumb to drugresistant infections; this is in addition to the tremendous number of lives lost due to
conditions complicated by the infection (CDC, 2013). Nearly 250,000 people each year
are hospitalized for Clostridium difficile infections, with the majority of cases attributed
to antibiotic use as a predisposing factor. It is estimated that at least 14,000 people die
each year as a result of this particular type of infection (CDC, 2013). The highestranking category of illness for which antibiotics are most commonly overprescribed is
respiratory infections (CDC, 2014a).
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Though the issue of antibiotic resistance is a worldwide concern, the already
overburdened US healthcare system finds itself particularly affected by the considerable
amount of avoidable cost. Antibiotic resistant infections, as compared to those easily
treated with antibiotics, necessitate additional or lengthier treatments, longer hospital
stays, more attention from healthcare workers, increased utilization of healthcare dollars
and are associated with greater morbidity and mortality. Though difficult to calculate,
estimates reveal that up to 20 billion dollars annually has been appropriated for excess
health care costs, with an additional 35 billion dollars in costs to society for lost
productivity of the workforce (Infectious Diseases Society of America, 2010). These
figures become particularly striking when taking into account that nearly 50% of
prescribed antibiotics are unwarranted or ineffectual as prescribed (CDC, 2013).
Contributing to the progression of antimicrobial resistance is the practice of using
antibiotics to prevent, control, treat and promote growth in animals (Hawkey & Jones,
2009). Though the US Food and Drug Administration (FDA) has undertaken measures to
eliminate the use of antibiotics for growth purposes, the practice is still prevalent. The
CDC (2013) stated that although unable to directly measure the amount of antibiotics
used in food animals versus humans, there is evidence supporting higher usage in the
production of food.
With the ever-growing presence of antimicrobial resistant strains of bacteria, the
risk for person-to-person transmission increases, as people and the surfaces they come in
contact with have now become the hosts, vectors, and vehicles for these deadly
organisms. While antibiotic resistance is somewhat of a matter of inevitability, measures
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must be undertaken to slow its progression and prevent new resistance from developing.
After much research for the Threat Report 2013, the CDC employed four core actions to
combat resistant infections: prevention of disease and its spread; following and
monitoring resistant bacteria; improving the utilization of antibiotics; and promoting
innovation for new drugs and diagnostic tests (CDC, 2013).
Utilizing the four-prong attack in addition to the fiscal year 2015 President’s
Budget request for funding to the CDC and National Healthcare Safety Network to
address the problem, the multitude of contributory factors can finally be addressed (CDC,
2014c). Many of the contributing factors have been presented as barriers to proper
prescribing. These include lack of patient education, patient expectation and subsequent
satisfaction, unbridled prescribing without antibiogram monitoring, a dearth of
antimicrobial stewardship programs, lack of prescriber support, cost, and a lack of
innovation on behalf of the pharmaceutical industry (Dovey, 2014). Barriers will
inevitably exist but must be overcome in order to achieve improved healthcare outcomes.
The purpose of this project was to explore current antimicrobial prescribing trends for
respiratory infections at an urgent care facility.
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Review of the Literature
A search of the MEDLINE, CINAHL, PubMed, Ovid, CDC, and World Health
Organization databases was conducted using the terms antimicrobial resistance, antibiotic
resistance, proper antimicrobial prescribing, antimicrobial stewardship, and prescribing
guidelines. The terms patient expectation and patient satisfaction were also linked with
antibiotic. The search was conducted for articles and information from 2006 to the
present, with inclusion of articles from 1996, 2002, 2003, 2004, and 2005 demonstrating
the longstanding knowledge of this worldwide issue and the lack of progress toward
improvement and resolution. The literature review will include the following subsections:
epidemiology; inappropriate antimicrobial/antibiotic use; antimicrobial/antibiotic
resistance; American College of Chest Physicians prescribing guidelines and use of those
guidelines in clinical practice; overall current antibiotic prescribing trends and trends
specific to respiratory illness; barriers to proper prescribing and improvement strategies;
and lastly antimicrobial stewardship.
Epidemiology
According to global statistics, pneumonia is the number one cause of death
worldwide and the sixth most common cause of death in the US (Dhar, 2012).
Pneumonia is the number one cause of death from infectious disease in the US and, in its
community-acquired form, is responsible for roughly 45,000 deaths annually (Dhar).
In 2014, the CDC released the 2011 edition of the National Hospital Ambulatory
Medical Care Survey. The survey is administered and collected by the Ambulatory and
Hospital Care Statistics Branch (AHCSB) of the National Center for Health Statistics for

5	
  
purposes of tracking the utilization and provision of care in emergency rooms and
ambulatory clinics throughout the US. According to the survey, 1,558,000 people visited
emergency rooms and ambulatory care clinics for visits characterized by and
subsequently coded as either bronchitis or pneumonia. Of these 1,558,000 people,
1,056,000 were over the age of 65 and thus vulnerable to increased morbidity and
mortality (AHCSB, 2011).
Though impressive at first glance, these numbers are gross underestimates of the
breadth of these annual diagnoses. This survey collects data only from those emergency
departments and outpatient departments of non-institutional general and short-stay
hospitals that choose to participate. Federally run institutions, urgent care/walk-in
clinics, and primary care offices are unaccounted for. This becomes particularly
significant when taking into consideration that the majority of cases of bronchitis and
pneumonia are managed outpatient. Only a small percentage of cases that end up in the
participating emergency rooms are tracked. When cough is the most common symptom
bringing patients to see their primary care doctors and acute bronchitis is the most
commonly bestowed diagnosis, this data seems skewed and appears much smaller than it
actually is (Albert, 2010).
Given that roughly 50% of all antibiotics are unwarranted or ineffectual as
prescribed combined with an inability to enumerate exactly how many people are
receiving these unwarranted prescriptions contribute significantly to the seemingly
uncontrollable cycle of the epidemiological evolution of resistance. Despite warnings,
providers continue to prescribe citing fatigue (Linder, Doctor, & Friedberg, 2014), patient
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expectation, and time constraints as justification to do so (Albert, 2010). Furthermore,
antimicrobial resistance has been able to strengthen in its adaptability and evolution via a
three-prong attack consisting of increased use of antibiotics (in both humans and
animals), greater movement of people, and increased industrialization (Hawkey & Jones,
2009).
A study conducted by Albrich, Monnet, and Harbarth in 2004 demonstrated a
direct correlation between outpatient antibiotic consumption and perpetuation of drug
resistant bacteria. The relationships between antibiotic use and the prevalence of the
following resistant bacteria were examined across 20 countries: penicillin non-susceptible
Streptococcus pneumoniae (PNSP), macrolide-resistant Streptococcus pneumonia
(MRSP), and Streptococcus pyogenes (MRGAS) (Albrich, Monnet, & Harbarth, 2004).
Total antibiotic use was correlated with PNSP (r = 0.75; p < 0.001), as was macrolide use
with MRSP (r = 0.88, p < 0.001), and MRGAS (r = 0.71; p = 0.004) (Albrich et al). The
results demonstrated highly statistically significant strong correlations between outpatient
antibiotic use and subsequent prevalence of drug resistant bacteria. After having studied
this trend across 20 counties, the researchers were able to conclude, with statistically
strong evidence, that streptococcal resistance was directly correlated with antibiotic
selection pressure on a national level (Albrich et al.)
Despite this and other studies that have provided tangible evidence supporting the
detriment of overprescribing, inappropriate use continues to occur. Even with heightened
awareness of overprescribing, the global mobility of people and food and increased
industrialization contribute to antibiotic resistance and it will likely continue to develop
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more rapidly than innovation (Hawkey & Jones, 2009). A primary target then is to slow
the spread of drug and multi-drug resistant infections, which contribute to the deaths of
23,000 people each year; this number will continue to rise if nothing changes and
inappropriate use continues (CDC, 2013).
Inappropriate Antimicrobial/Antibiotic Use
The proper utilization and prescription of antibiotics and antimicrobials carries
with it the ability to thwart bacterial resistance, decrease excess healthcare costs, and
optimize the patient experience and outcome (Deuster, Roten, & Muehlebach, 2010).
Rates of inappropriate antimicrobial/antibiotic therapeutic intervention are estimated to
be as high as 25-50%. Reasons contributing to this gross excess include unwarranted
prescriptions, longer than necessary treatment length, inaccurate dosing, and inadequacy
of drug versus pathogen-susceptibility (CDC, 2013). Consequentially, this practice
causes an increase in adverse events and reactions, increased mortality, lengthened
hospitals stays, and excessive healthcare costs (Deuster et al., 2010). Each year, roughly
$1.1 billion dollars is spent on the estimated 41 million unnecessary antibiotic
prescriptions for patients experiencing viral respiratory tract infections; this does not
include the excess healthcare costs related to the adverse effects and complications of
unwarranted pharmacotherapy (Fendrick, Monto, Nightengale, & Sarnes, 2003).
An example of inappropriate use was epitomized in a retrospective review of
billing and electronic medical record data regarding time of prescription. Data were
collected from over 20,000 adult patients at 23 health centers and revealed a significant
relationship between provider fatigue and inappropriate antibiotic prescription (Linder et
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al., 2014). The odds ratio steadily increased as time passed during the patient care
session. The ratios increased from the first hour to 1.01 in the second hour, 1.14 in the
third hour, and 1.26 in the final hour, establishing a pattern of decision fatigue (Linder et
al.). The study, however, never discussed methods for addressing and reducing the
effects of decision fatigue.
Further exploration surrounding the prevalence and consequence of inappropriate
antimicrobial use lead to a systematic review and meta-analysis conducted to examine
subsequent antibiotic resistance in patients’ prescribed antibiotics (Costelloe, Metcalfe,
Lovering, Mant, & Hay, 2010). The review included 24 studies, 22 of which involved
symptomatic infection and two involved healthy volunteers; 19 were observational
studies and five were randomized trials (Costelloe et al.).
In seven studies (2,605 participants) particular to respiratory bacteria, the pooled
odds ratio for resistance was 2.4 within two months of antibiotic treatment and at twelve
months of treatment. Multiple studies reported that the quantity, duration, and number of
courses were directly associated with higher rates of resistance (Costelloe et al., 2010).
Only one prospective study showed changes in odds ratios over a period of time falling
from 12.2 at one week to 6.1 at one month, 3.6 at two months, and 2.2 at six months. The
authors concluded that patients prescribed antibiotics for respiratory infections developed
bacterial resistance to that antibiotic. The effect is greatest in the month immediately
following and gradually tapers, but can persist for up to a period of 12 months. Not only
does this facilitate patients’ becoming vectors for organisms resistant to first line
antibiotics, but this also potentiates the overuse of second line antibiotics.
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This residual year long resistance is a likely catalyst behind the widespread
antibiotic resistance in the community when antibiotics are appropriately prescribed, and
more concerning when antibiotics are overprescribed and unwarranted. The author noted
that after years of inappropriate use and pervasive defiance, clinicians still do not see
antibiotic resistance as a reason to refrain from unnecessary antibiotic use (Costelloe et
al., 2010). The detriment is tangible and increasing at an alarming rate.
Antimicrobial/Antibiotic Resistance
Antimicrobial resistance was first identified in the 1940s with the discovery of
penicillin resistant Staphylococcus aureus (Schofield, 2011). Roughly 20 years later
came the advent of what is largely the most well known of resistant organisms,
methicillin-resistant Staphylococcus aureus (MRSA). As time progressed, so too did
resistance. In the 1990s, the appearance of extended spectrum B-lactamases (ESBL)
emerged as the greatest concern for infectious-disease specialists and public-health
officials to date. Bacteria utilize ESBLs in a way such that multiple drug resistance is
conferred (Schofield). This has been an important contributing factor to the development
of hospital-acquired and community-acquired infections.
Bacteria are classified by four broad categories: oxygen requirements (aerobes
[versus] anaerobes); cell wall (gram-positive vs. gram-negative); shape (cocci vs. rods)
and atypical features (Haddock, 2013). Aerobes require an oxygenated environment to
survive. In contrast, anaerobes have adapted to survive in poorly oxygenated areas such
as the mouth, and intestinal and genital tracts (Haddock). The cell wall components
differentiate bacterial types by thickness.

10	
  
Gram-positive bacteria possess a thick peptidoglycan cell wall capable of
retaining a Gram stain. Bacteria can be further divided into cocci and rods. Common
Gram-positive cocci include staphylococci (skin), streptococci (group A & group Bhemolytic – throat; group B. Streptococcus – genital tract; S. pneumoniae – lungs)
(Haddock, 2013). Common Gram-positive rods include Clostridium and Listeria
(Haddock).
Gram-negative bacteria possess a thin peptidoglycan cell wall incapable of retain
a Gram stain. Common Gram-negative cocci include Neisseria menigitidis, Neisseria
gonorrhoeae, and numerous respiratory microbes (Haddock, 2013). Common Gramnegative rods include bowel pathogens such as E. coli, Salmonella spp., Shigella spp.,
and H. pylori, as well as respiratory microbes such as H. influenza (Haddock).
Atypical pathogens differentiate themselves from other bacteria by characteristics
that do not conform to the broad categories. An example of an atypical pathogen is
Mycobacteria tuberculosis. Mycobacteria, similar to Gram-positive bacteria, possess a
thick cell wall, however the cell wall is lipid based instead of peptidoglycan based
(Haddock, 2013). Another example of atypical pathogens is the small intracellular
organism known as Chlamydia. They do not have their own cell and thus must rely on
other cells for survival (Haddock).
Antibiotic or antimicrobial (antiviral, antibacterial, antifungal) resistance to the
mechanism of action of antimicrobial drugs can occur in two ways: innate and acquired
(Gascoigne, 2014). If a type of bacteria is innately resistant to a class of drugs, it means
that all strains of that particular bacteria are resistant to all members of that antimicrobial
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class (Gascoigne). Acquired resistance is a case of natural selection in its most basic,
but deadly form. Repeated exposure to the same antimicrobial causes bacteria to gain
familiarity with the antimicrobial agent and ultimately acquire resistance to it. The
surviving resistant bacteria replicate, whereas the susceptible bacteria are eliminated.
The survival of these fittest bacteria allows for the propagation of resistance to future
bacterial generations (CDC, 2013).
There are three processes by which bacteria may go about obtaining resistance:
enzymatic barrier mechanism; mechanical barrier mechanism; and target protection
barrier mechanism (Gascoigne, 2014). The enzymatic barrier mechanism is the most
common and utilizes a modified version of an already existing enzyme. The modified
enzyme is able to cleave or alter the antimicrobial, rendering it inactivated and useless
(Gascoigne). Using the mechanical barrier mechanism, the bacteria has the ability to
alter the permeability of its cell membrane, thereby limiting the amount of antimicrobial
allowed into the cell such that the minimum effective concentration is not reached
(Gascoigne). Additionally, bacteria may possess outflow pumps that transport the
antimicrobial out of the cell before it is able to reach its target destination and be
effective. Lastly, the target protection barrier mechanism utilizes a decoy method. The
bacteria are able to mutate such that they create decoy target sites to which the
antimicrobial agent is lured. Some bacteria may also produce a protective molecule that
hides the target site from the antimicrobial by way of providing a mask of sorts
(Gascoigne).
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The process of acquiring resistance, regardless of the method, involves the
transfer of resistant deoxyribonucleic acid (DNA). There are two ways in which this can
occur: vertical gene transfer and horizontal gene transfer (Gascoigne, 2014). Vertical
gene transfer propagates resistance from genetically superior bacteria to future
generations, this is known as the “survival of the fittest” tactic. Horizontal gene transfer
involves the transfer of small pieces of DNA from one bacteria to another of the same or
different species. This occurs by: cell-to-cell contact (conjugation), the uptake of DNA
from the environment (transformation) or the utilization of bacteriophages (bacteriaspecific viruses) as a vehicle for transport between two related bacteria (transduction)
(Gascoigne).
Despite the urgency for solutions to the ever-growing issue of bacterial resistance,
clinical research is severely lacking with respect to randomized controlled trials. This
dearth of research is attributed to the severity of illness in the population that would be
examined, as well as unwillingness on behalf of the pharmaceutical industry to fund such
studies until new antibiotics, capable of eliminating multi-drug resistant organisms, have
been developed (Infectious Diseases Society of America, 2010). Much of the stagnation
with respect to antimicrobial resistance research is due to the lack of appropriation of
funding and whether those funds should be allocated toward improving the old antibiotics
or developing new ones. This lack of progress with evidence-based research serves to
explain why current research articles and principles often cite older information and
guidelines. Thus, it is important that the US FDA demand and expect studies of patients
at high risk for developing multi-drug resistant infections (Paterson & Rogers, 2010).
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American College of Chest Physicians Prescribing Guidelines
In 2006, the American College of Chest Physicians (ACCP) in conjunction with
the CDC developed clinical practice guidelines in order to potentially enhance a
clinician’s ability to practice evidence-based medicine. It is the position of the ACCP
that these clinical guidelines are to be used in conjunction with clinical judgment, with
the understanding that the recommendations may not apply to every patient and may be
affected by patient preference and resource availability (Irwin, 2006). The ACCP
acknowledges that these guidelines are recommendations, not mandates, and as such may
not always be applicable as there will always be exceptions (Irwin).
Every recommendation found within the expansive list of guidelines that ACCP
has set forth is graded based upon two components. These two components are quality of
evidence and the net benefit of the diagnostic and therapeutic procedure. The levels of
evidence are as follows: A, strong; B, moderate; C, weak; D, negative; I, inconclusive (no
recommendation possible; E/A, strong recommendation based on expert opinion only;
E/B, moderate recommendation based on expert opinion only; E/C weak
recommendation based upon expert opinion only; and E/D negative recommendation
based on expert opinion only (Irwin, 2006).
The ACCP guidelines state that for patients with acute cough and sputum
production suggestive of acute bronchitis, the absence of the following findings
sufficiently reduces the need for chest radiography: heart rate >100 beats/min, respiratory
rate >24 breaths/min, oral temperature >38°C, and evidence of consolidation upon chest
examination (Irwin, 2006). Though this quality of evidence was found to be low, the
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benefits of lowering exposure to radiation whenever possible are substantial and, as
such, this recommendation was ranked as a category B (Irwin). Another recommendation
states that for patients with a presumed diagnosis of acute bronchitis, routine treatment
with antibiotics is not warranted and should not be offered (Irwin). The quality of
evidence for this recommendation was found to be good and without benefit, and was
ranked as a category D meaning a negative recommendation or to be recommended
against (Irwin). Lastly, for patients with a diagnosis of acute bronchitis, decisions to not
use antibiotics should be discussed with patients on an individual basis and explanations
should be offered due to patient and public expectation to receive an antibiotic based on
prior experience (Irwin). The quality of evidence for this recommendation was purely
expert opinion and showed intermediate level of benefit, thereby earning this
recommendation a category E/B grade of recommendation (Irwin).
According to the CDC, the most common types of infections for which antibiotics
are prescribed are lung infections. Roughly 22% of all antibiotics are prescribed for lung
infections, almost one and one-half-times more than the next highest ranking of 14% for
urinary tract infections (CDC, 2014a). The most common types of lung infections
include acute and chronic bronchitis and pneumonia. Acute bronchitis is largely thought
to be viral in origin and often does not warrant an antibiotic (Irwin, 2006). In the past,
should a patient experience a fever with an increase in dyspnea and volume or purulence
of sputum, the illness was treated as an exacerbation of chronic bronchitis and antibiotics
were prescribed (Deuster et al., 2010). Studies have shown that antibiotics are no longer
indicated for acute uncomplicated bronchitis and sputum cultures for suspected acute
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bronchitis have proven unsuccessful in determining the need for an antibiotic.
Treatment is reserved solely for patients with an acute exacerbation of chronic bronchitis
and/or chronic obstructive pulmonary disease (Wong, Blumberg, & Lowe, 2006).
If the symptoms are greater in severity, bacterial pneumonia or community
acquired pneumonia become part of the differential diagnoses. These diagnoses are
characterized by the presence of acute onset fever of 38°C or greater, tachypnea at or
above 24 breaths/minute, tachycardia at or above 100 beats/minute and evidence of
consolidation on chest exam including rales, egophany, or fremitus (Irwin, 2006). Chest
radiography should be performed for patients for whom complete recovery is the goal.
This is performed as a confirmation of physical exam findings, to assess the severity and
to establish a baseline radiograph for confirming resolution (Irwin). The diagnosis of
bacterial pneumonia is made largely upon clinical assessment data and radiography as
sputum cultures are unavailable unless in the inpatient setting.
For many years the initial empirical treatment of pneumonia was largely
‘organism-based’ as it was thought that the causative agents manifested themselves
differently both in physical exam and on radiograph. Though this method may have
benefited some patients, the area of overlap for pathogens’ location preference within the
lung was far too large. According to Christiansen (1996), well-controlled studies
utilizing radiographic parameters to predict the type of pathogen showed a positive
correlation in less than 50% of cases.
Patients with underlying illnesses are predisposed to infection. As mentioned
previously, most common and concerning of these underlying illnesses is COPD. The
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respiratory tracts of patients with COPD are colonized by Streptococcus pneumoniae,
Haemophilus influenzae and Moraxella catarrhalis, which predisposes patients to have
more frequent exacerbations or infections (Dhar, 2012). Patients may also be
predisposed to pathogens if they have any of the following comorbidities: smoking
history, diabetes mellitus, renal disease, congestive heart failure, alcoholism, altered
mental status, or patients post-splenectomy (Irwin, 2006).
A traditional approach to the selection of empirical therapy has incorporated three
risk factors for patient morbidity and mortality. These contributory risk factors include
age, underlying illness, and severity of illness. Patients over the age of 60 should be
treated more aggressively than those in lower age brackets as these patients experience a
much higher morbidity and mortality (Ramsdell, Narsavage & Fink, 2005). Additionally,
research has shown that some age groups find themselves particularly susceptible to
certain pathogens. The elderly are much more susceptible and likely to acquire
Streptococcus pneumoniae, though it does occur in all age groups, whereas those between
the ages of 20-40 are more likely to acquire Mycoplasma pneumoniae (Ramsdell et al.).
Properly prescribing antibiotics is of utmost importance for optimal patient
response due to exacerbations of chronic bronchitis and pneumonia. The aforementioned
recommendations for antibiotics offer adequate coverage for each of the previously
discussed conditions. In cases where more than one drug can offer coverage, the
antibiotic chosen should be the one that the patient is most likely to take, have the fewest
side effects, and the lowest cost (Irwin, 2006).
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Since the development of the guidelines, some research has been conducted
related to usage. For example, a 2010 study conducted by Linder, Schnipper, Tsurikova,
Volk and Middleton examined self-reported antibiotic therapy guideline familiarity and
subsequent antibiotic prescribing practices. The clinicians in the study were asked to
rank their familiarity with the ACCP/CDC antibiotic guidelines on a Likert scale ranging
from ‘not at all’ to ‘extremely’ familiar. In the review of 11,164 non-pneumonia acute
respiratory infection cases treated by the clinicians, 44% were prescribed antibiotics.
Clinicians that reported their familiarity as ‘not at all’ (n = 15), ‘somewhat’ (n = 62),
‘moderately’ (n = 93), and ‘extremely’ (n = 38) prescribed antibiotics in 42, 37, 46, and
46% of cases respectively (p < 0.001). The authors concluded that self-reported
familiarity with the ACCP/CDC guidelines for antibiotic treatment for acute respiratory
infections appeared to be associated with increased prescribing. Findings suggest that
familiarity with guidelines does not necessarily correlate with adherence to the guidelines
or higher patient outcomes (Linder et al.).
While guidelines are supposed to be based upon the most current and up to date
research, they are also expansive, encompassing, and time-consuming to produce.
Although the ACCP guidelines are from 2006, they are still the ultimate resource for
practice guidelines and standard of care for prescribers and should be adhered to as
closely as possible.
Antibiotic Prescribing Trends – Overall
According to the CDC’s study published in the New England Journal of Medicine
(2013), it is estimated that healthcare providers prescribed 258 million courses of
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antibiotics, which translates to 833 prescriptions per 1000 people, or four out of five
(Hicks & Taylor, 2013). While antibiotic-prescribing rates declined in the 1990s, they
have been steadily rising since then (Ashiru-Oredope, Sharland, Charani, McNulty, &
Cooke, 2012).
Every winter, antibiotic resistance experiences a rise that is in direct proportion to
an increase in antibiotic prescriptions (Walker, 2012). A study conducted by Johns
Hopkins University found that cold weather-related prescribing and subsequent resistance
was an additive result of drug popularity and extreme weather changes (Walker).
Another, cohort-style study utilized a time-series analysis from 1999 to 2007 on
antibiotic usage from Intercontinental Marketing Services (IMS) Health and antibiotic
resistance from The National Surveillance (Sun, Klein, & Laxminaryan, 2012). The
authors found that rates of resistance fluctuated greater than 6% in a pattern similar to
rates of prescribing (Sun et al.). A significant correlation between the prevalence of
resistant E. coli and the prescription of aminopenicillins approximately one month prior
was detected (p = 0.03). Similar results, (p = 0.03), were found for the prevalence of
ciprofloxacin-resistant MRSA and the prescription of fluroquinolones one-month prior
(Sun et al.). The authors concluded that the seasonal increase of antibiotic prescriptions
being filled were likely causing community resistance and could be directly correlated to
the frequency with which patients visited outpatient settings (Sun et al.).
Antibiotic Prescribing Trends – Respiratory
Roughly 90% of cases of uncomplicated acute bronchitis have nonbacterial
etiologies and, therefore, would not benefit from antibiotic therapy (Evans et al., 2002).

19	
  
A randomized controlled-trial was conducted to support this theory. Patients that were
diagnosed with acute bronchitis were randomized into one of two groups. One of the
groups received azithromycin (n = 112) and the other vitamin C placebo (n = 108).
Differences in health-related quality of life were measured on day seven and were found
to be small and clinically insignificant (p = 0.8). Eighty-nine percent of patients in both
the azithromycin group (n = 100) and the placebo group (n = 96) returned to normal day
activities by day seven (p > 0.9). The study showed that while there was an evident
reduction of cough at follow-up (number needed to treat = 5.6) there was no change in
the patients’ activity limitations. The study also showed that the number needed to harm,
based upon the antibiotics’ adverse effects, was 16.7 (Evans et al.). The results showed
that at days 3 and 7 there were no differences between the two groups and 89% of
patients in each group showed clinical improvement. Therefore, there was no advantage
in prescribing azithromycin versus low-dose vitamin C for acute bronchitis (Evans et al.).
A study of 807 patients diagnosed with acute lower respiratory infection,
including those with fever and purulent sputum, were assigned into one of three treatment
groups: immediate antibiotic; delayed antibiotic; or no antibiotic (Little et al., 2005).
These groups were each further divided into two groups. One group was given a one
page information leaflet about the diagnosis natural history as well as answers to patients’
most frequently asked questions and advice on when to seek additional treatment and the
other group was not given any information. It was found that the information leaflet had
no effect on outcomes. In comparison to the group that received an immediate antibiotic,
only a portion of patients in the delayed treatment and no treatment groups went on to fill

20	
  
antibiotics (96%, 20%, and 16% respectively; p<0.001). The study concluded there
were no significant differences between groups and as such delayed antibiotics or no
antibiotics were acceptable approaches (Little et al.).
In a study conducted between December 2007 and November 2008 (Walker,
2012), in both public and private facilities, current prescribing rates for uncomplicated
respiratory tract infections were examined. At least one antibiotic was prescribed for an
acute respiratory tract infection 45% of the time in public facilities and 57% of the time
in private facilities. In the public facilities, penicillins were the main class of antibiotics
prescribed (31%), followed by macrolides (25%), fluoroquinolones (20%), and
cephalosporins (10%). This study clearly illustrates unmitigated amounts of
overprescribing, as uncomplicated respiratory infections are largely due to viruses.
More recently, a 2009 cohort study conducted by Grijalva, Nuorti, and Griffin
used data from the National Ambulatory Medical Care Survey and National Hospital
Ambulatory Medical Care Survey to assess and analyze trends in antibiotic prescribing
for acute respiratory tract infections from 1995 through 2006. Antibiotic prescription
rates for non-otitis media acute respiratory tract infections, for which antibiotics are
rarely indicated, decreased by 24% (Grijalva, Nuorti, & Griffin, 2009). This trend was
true for all penicillins, cephalosporins, sulfonamides, and tetracycline; however this was
not the case for azithromycin and fluoroquinolones. Prescription rates for azithromycin,
and fluoroquinolones increased significantly among adults (Grijalva et al.). While a
decrease in antibiotic use may appear to be a step in the right direction, this particular
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shift represented a decrease in targeted therapy and an uptrend in broad-spectrum
coverage (Grijalva et al.).
Resistance begins in the community and impacts resistance in the inpatient
setting. In sum, a community’s prescribing trends, especially shifting to broader
spectrums of coverage in lieu of appropriately targeted therapies, impacts the level of
resistance in that community. It then potentiates sicker people with more resistant
pathogens, who must seek care in hospital settings, thereby increasing prevalence of the
resistant pathogens (Walker, 2012). In order to prevent this cycle from continuing, it is
necessary to address factors contributing to inappropriate prescribing, to prescribe
according to the guidelines, and to meet these barriers with appropriate and well thought
out strategies for resolution.
Barriers to Proper Prescribing & Improvement Strategies
Barriers to appropriate antimicrobial prescribing have been researched and
explored, though the problem has not been solved. Barriers include, but are not limited
to, lack of patient confidence in their practitioner, patient expectation and satisfaction,
and defensive prescribing in fear of malpractice liability (Crombie, 2012). Prescribers
must first and foremost ensure that they have undergone the training necessary to achieve
a solid understanding of pharmacotherapeutics. Not only must the prescriber possess
confidence in their prescribing methods, but other members of the healthcare team,
including patients, must have faith in the prescriber’s ability to accurately and adequately
prescribe (Blanchflower, Greene, & Thorp, 2013). The ability to properly prescribe
medication to treat disease is a major factor in the establishment of a trusting rapport with
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patients, without which a connection between patient and prescriber will not be made
and healing will not take place (Blanchflower et al.).
Contributing to the development of a patient-prescriber relationship is patient
expectation and subsequent satisfaction. Often, patients expect an antibiotic to treat an
acute respiratory infection (Wong et al., 2006). Given that patient satisfaction is a main
priority for the provider and the institution for which they work, prescribers feel
pressured to prescribe an unnecessary antibiotic (Wong et al.). On the other hand, when
patients are not given their requested, yet unwarranted, dose of antibiotics, the rationale
behind the prescriber’s decision is often not adequately explained due to time constraints.
This can lead to lack of trust, malcontent, and even anger. Dissatisfaction is especially
detrimental when patient satisfaction surveys, which often affect prescriber raises and/or
bonuses, shed a negative light upon the prescriber despite having done what was
medically prudent (Crombie, 2012).
Occasionally, prescribers will provide unnecessary antibiotics to patients in
attempt to mitigate the potential for malpractice should something that was not evident on
assessment or testing be missed. In 1994, the Congressional Office of Technology
Assessment (OTA) supplied a definition for defensive medicine that is still used today:
“Defensive medicine occurs when doctors order tests, procedures, or visits, or
avoid high-risk patients or procedures, primarily (but not necessarily or solely) to
reduce their exposure to malpractice liability. When physicians do extra tests or
procedures primarily to reduce malpractice liability, they are practicing positive
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defensive medicine. When they avoid certain patients or procedures, they are
practicing negative defensive medicine” (U.S. Congress OTA, 1994, p.13).
The OTA expanded the definition to include over prescribing in attempts to
provide coverage for medical uncertainty (U.S. Congress OTA, 1994).
Detecting the prevalence of defensive medicine is very difficult. The ways in
which data can be collected are limited to surveys or linking differences in physician
procedure utilization rates to differences in risk of liability (Manner, 2007). In attempts
to obtain tangible data, a poll of 300 physicians and other hospital staff was conducted.
Seventy-nine percent reported that malpractice litigation had hurt their ability to provide
quality care to patients, 41% reported over prescribing antibiotics, and 73% reported
knowledge of colleagues prescribing in that same fashion (Manner). The study revealed
that 66% of the 100 nurses and 100 hospital administrators reported unnecessary testing
out of fear for litigation (Manner).
In 2010 a similar survey was conducted. A total of 89 gerontological physicians
were evaluated in six clinical vignettes based upon their knowledge of the Beers criteria
regarding medications to avoid in the elderly (Ramaswamy et al., 2011). During the
debriefing portion of the survey, the physicians had an opportunity to rank perceived
prescribing barriers (Ramaswamy et al.). Responses included the following perceived
barriers:
“Patient taking large number of medications (91%)
Cost to patient (89%)
Potential drug interactions (87%)
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Limited options on insurance formularies (85%)
Lack of time in office schedule (67%)
Difficulty communicating with other doctors (61%)
Lack of information about patient’s present medications (60%)
Lack of formal education on prescribing for the elderly (54%)
Lack of acceptable therapeutic alternatives (47%)
Patient’s request to maintain a specific medication (41%)
Unwillingness to discontinue a medication started by another doctor (34%)
Patient’s request to begin a specific medication (26%)
Lack of access to pharmacist (16%)” (Ramaswamy et al., 2010, p. 1156)
Though some of the barriers are inevitable and difficult to navigate around, many
are able to be quelled with simple solutions and learning opportunities (Blanchflower et
al., 2013). If it is a matter of prescribing confidence, all prescribing clinicians should be
encouraged to enroll in pharmacology continuing education classes as appropriate and
available in order to fulfill, and go above and beyond, state specific requirements
(Blanchflower et al.).
Rhode Island physicians are required to partake in 40 hours of continuing
education, with a minimum of two hours applied to current public health needs (Rhode
Island Department of Health [RIDOH], 2014). Physician’s assistants are mandated to
attend 30 hours of continuing education without specification of type (RIDOH). Nurse
practitioners must complete at least 30 hours of continuing education in pharmacology

25	
  
every six years, however they may apply the 10 hours of continuing education
biennially as required for their RN license to those 30 hours (RIDOH).
The provider caring for a patient with a viral illness needs to be prepared to
provide a thorough explanation regarding why an antibiotic should not be prescribed and
educate the patient on the difference between a viral versus a bacterial infection (Wong et
al., 2006). Additionally, the provider may provide and educate the patient on the use of
symptomatic relief measures including antipyretics, decongestants, non-steroidal antiinflammatories, antitussives and antihistamines as appropriate. Another useful technique,
described in the literature, is providing patients with a prescription for an antibiotic, but
requesting that the patient not fill it unless the symptoms worsen or persist after a certain
number of days (Wong et al.). For patients for whom an antibiotic is entirely
unwarranted, developing an open communication plan and ensuring easily accessible
follow-up will often times quell the anxiety patients may develop regarding not getting an
antibiotic (Wong et al.). Prescribers have noted patients’ desire to leave with something
tangible in order to feel as though the visit was worthwhile. It has been reported by
clinicians that patients leaving with a discharge summary with contact information,
information pamphlets about their diagnosis, a non-antibiotic prescription, or a note for
work exude much more satisfaction with their visit than those leaving empty-handed
(Blanchflower et al., 2013).
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Antimicrobial Stewardship
A major effort to control and monitor antimicrobial resistance is gaining
recognition worldwide through the implementation of antimicrobial stewardships.
According to a report by the CDC (2014b), antimicrobial stewardship programs can help
clinicians properly treat infections, reduce adverse reactions, aid practitioners in
improving quality and safety of care, increase treatment success, decrease treatment
failure, and provide guidance for proper therapeutic and prophylactic prescribing.
Though initially developed for inpatient settings, antimicrobial stewardships have
been found to be able to adapt to meet the differing requirements of a variety of settings
so long as the core principles remain intact (CDC, 2014b). The CDC has identified the
following seven core elements crucial to the successful implementation of a stewardship:
leadership commitment; accountability; drug expertise; action; tracking; reporting; and
education. In order to properly execute the program, adequate staffing, as well as
financial, and technological resources must be allotted. This includes the appointment of
a responsible program leader as well as a lead pharmacist to oversee the implementation
and evaluation of at least one program action, such as an “antibiotic timeout” (CDC).
Technological resources such as tracking software must be purchased and assigned staff
must become trained to operate the software. Results of tracking must then be
appropriately disseminated to relevant staff in the form of facility-specific antimicrobial
education (CDC).
As far back as 15 years ago, studies were demonstrating the benefits of
antimicrobial stewardship programs. A prospective study of 655 infected patients who
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required admission to an intensive care unit was conducted to examine outcomes for
patients whose care was guided by an antimicrobial stewardship program versus those
whose care was not (Kolleff, Sherman, Ward, & Fraser, 1999). Patients for whom care
was guided by antimicrobial stewardship received targeted pharmacotherapy allowed for
by in vitro cultures predicating bacterial susceptibility to the prescribed antimicrobial.
Those patients for whom care was not guided by antimicrobial stewardship strategies
received broad-spectrum antimicrobial coverage. The authors discovered a significantly
lower rate of infection-associated mortality for patients who received appropriate
antimicrobial therapy as compared to those who received inappropriate therapy. The
mortality rate for patients that received appropriate therapy was 18% as compared to 42%
for those who did not (p < 0.001) (Kolleff et al.).
A cross sectional, stratified study of U.S. hospitals conducted in 2006 displayed
similar results (Zillich et al., 2006). The study examined the relationship between
stewardship strategies and antimicrobial resistance trends. A survey inquiring about the
implementation and dissemination of information regarding practice guidelines, use of
antimicrobial-related technology such as antibiogram mapping and support tools, and
communication with prescribers was sent to the infection control leaders at 670 hospitals
across the US. Additionally, data were collected regarding prevalence of the four most
epidemiologically significant drug-resistant pathogens: methicillin-resistant
Staphylococcos aureus, vancomycin-resistant Enterococci, ceftazidime-resistant
Klebsiella, and quinolone-resistant Escherichia coli (Zillich et al.).
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The results displayed that the implementation of antimicrobial stewardship
strategies regarding recommended antimicrobial use (p < 0.01) and the optimization of
the duration of empirical antibiotic prophylaxis (p < 0.01) were associated with a lower
prevalence of antimicrobial resistance. In contrast, restrictive formularies were found to
be associated with a higher prevalence of antimicrobial resistance (p = 0.05). In sum, the
study concluded that the implementation of guideline-recommended practices and
stewardship strategies to control and guide antimicrobial selection and prescription
appears to help control antimicrobial resistance rates in the U.S. (Zillich et al., 2006).
If and when antimicrobial stewardship programs are implemented, program
evaluation and quality assurance and improvement must be conducted to determine the
efficacy of the program (Looke & Duguid, 2011). While some hospitals may employ
antibiogram software to monitor prescribing trends, many of the other core elements are
not performed, rendering the program essentially ineffective. It is imperative that all of
the requirements of the core elements are implemented and evaluated in the inpatient
setting so that those antimicrobial stewardship programs can serve as a template, which
can be adapted and utilized in various other settings.
Critique of the Literature
While the current literature surrounding antimicrobial resistance is
overwhelmingly vast, more research needs to be conducted in the form of statistical
analysis utilizing data from antimicrobial stewardship programs. Older studies have
shown consistent correlations between prescribing trends and subsequent trends in
resistance. Unfortunately, much of the more current research takes the form of
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systematic reviews, which discuss results from studies no longer considered to be
current. Therefore, although hospitals may hesitate to invest the immense amount of
time, energy, finances, and manpower, the return on investment should speak for itself as
direct excess healthcare cost decreases as a direct result of the program.
Another area for further investigation includes researching various settings in
which antimicrobials are prescribed, as the majority of studies are performed within the
inpatient setting. Just as hospitals may hesitate to invest, so too will other settings in
which the cost-benefit analysis may not be as evident. Exploring different ways to shape
the antimicrobial stewardship programs to meet the needs of various settings would prove
beneficial.
The purpose of this project was to explore current antimicrobial prescribing trends
for respiratory infections at an urgent care facility. The research question motivating this
project was: What are the antimicrobial prescribing trends for respiratory infections at an
urgent care facility as compared to the national average?
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Theoretical Framework
The ACE Star Model of Knowledge Transformation (Stevens, 2004) was utilized
to serve as a guide in conducting this research study. The model was primarily developed
to address obstacles to the thorough utilization and implementation of ever evolving
evidence-based practice (EBP). Two overarching hurdles were identified: the complexity
of knowledge, including volume, and the form of the knowledge available (Stevens).
The theory guides the understanding of the evolution of knowledge in all of its
forms, cycles, and characteristics. Furthermore the theory lays a framework for
seamlessly integrating newly acquired knowledge with older concepts. The model
depicts various stages of the evidence-based practice processes that occur as new
knowledge is discovered and transformed into practice (Figure 1). The five-step model
represents a systematic approach to putting evidence-based practice processes into effect.
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Figure 1. Ace Star Model of Knowledge Transformation.
Stevens (2004) stated, “Not only is the volume of literature a hurdle, but the form
of the knowledge is a hurdle as well. Literature contains a variety of knowledge forms,
many of which are NOT suitable for direct practice application” (p. 1). Using a model
that utilizes a step-wise system of checkpoints, vast amounts of information can be
organized into something of value to clinicians and employed as a new frame of reference
for clinical decision-making.
In a campaign by the CDC (2014a) to improve antibiotic prescribing practices, a
model was instituted to help incorporate necessary change. The model, in striking
resemblance to the ACE Star Model, also contained five steps arranged in a star-like
shape (Figure 2). In addition to providing the framework for integrating new knowledge

32	
  
into practice, the model was able to blend the research aspect with diagnosis-specific
clinical guidelines that help clinicians with ‘in the moment’ decision making.

Figure 2. Improving Antibiotic Prescribing in Hospitals.
The ACE Star Model of Knowledge Transformation (Stevens, 2004) was
extremely useful in guiding this research project. As antimicrobial resistance trends
cycle and fluctuate so to must the prescribing practices that influence them. Given the
ever-evolving nature of science, medicine and life, clinicians must embrace the neverending opportunities for learning and find a harmony between intuition from experience
and the advent of new organisms and drugs. Given that this research project focuses on
one particular time frame, the model serves as an organizational tool for collecting

33	
  
massive amounts of continually changing information in a step-wise and incremental
fashion. Utilizing this type of model will allow for seamless incorporation of and
expansion upon the resulting conclusions.
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Methodology
Purpose & Research Question
The purpose of this project was to explore current antimicrobial prescribing trends
for respiratory infections at an urgent care facility. The research question was: What are
the antimicrobial prescribing trends for respiratory infections at an urgent care facility as
compared to the national average?
Background
The providers working at urgent care facilities face a unique set of barriers to
prescribing due to the inherent nature of the practice. Such barriers encountered in the
urgent care setting include lack of follow-up, time constraints, lack of insurance, and
patient satisfaction and expectation. While it is the goal of all providers to follow
evidence-based practice guidelines for antimicrobial prescribing, this may not always
occur. It was not the purpose of this project to determine why overprescribing may
occur, but rather to explore how often it was occurring.
Design
The design for the research project was a non-experimental retrospective chart
review.
Site
The study was conducted at Concentra Urgent Care and Occupational Health in
Warwick, Rhode Island. Concentra provides services to patients seeking treatment for
non-life threatening illnesses and injuries. In addition, Concentra provides a wide-range
of occupational health services to support employers in maintaining a healthy workplace.
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Of the more than three hundred Concentra facilities across 40 of the 50 states, the
Warwick, Rhode Island location is the busiest urgent care facility in the nation. This
researcher did not have authorized access to site-specific census information as these
documents are protected internally. However, based on the researcher’s work experience
and observation, approximately 30 to 70 urgent care patients are seen at Concentra
Warwick each day, 363 days per year. Of those visits, the researcher estimated that
roughly one-third of all visits are due to respiratory complaints. Urgent care patients may
see any of the six medical doctors (MDs), two physician assistants (PAs), or four nurse
practitioners (NPs) depending on the rotation of the schedule.
Sample
The inclusion criteria were the ICD-9 codes for the following diagnoses: cough;
bronchitis; pneumonia; and upper respiratory infection (as characterized by acute
bronchitis) for any adult patient seen between January 1, 2014 and October 1, 2014.
Exclusion criteria included: pediatric patients; patients for whom symptom severity
warranted a transfer to the hospital; and patients whom had multiple confounding
diagnoses for which an antibiotic may have been prescribed. A maximum of 200 charts
were approved for review.
Measurement
The researcher developed a data collection tool based on the literature and clinical
experience that was utilized to collect and organize data. The tool included: age,
diagnosis, ICD-9 code, symptoms, if there is an underlying diagnosis of COPD, if a CXR
was performed, prescriber credentials, insurance status, if an antibiotic was prescribed,
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and if so whether or not the prescription was appropriate in accordance with the ACCP
guidelines. Most importantly, the data analysis examined whether or not the patient met
the criteria to warrant a prescription for an antibiotic. The specific criteria warranting
treatment included: fever > 38°C; respirations > 24 breaths/min; heart rate > 100;
evidence of consolidation upon physical exam or confirmation of infiltrate on chest x-ray.
A patient need not meet all the criteria in order to be diagnosed and subsequently treated
appropriately, as every patient, immune response, and course of illness is different.
Therefore, an only slightly tachycardic, afebrile patient that shows no signs of tachypnea
may exhibit evidence of consolidation upon physical exam and subsequently have
infiltrates on x-ray. As such, the inevitable variability in the guidelines due to inherent
differences in patients may account for their overly wide interpretation.
To reiterate, this study did not focus on whether or not the patient was treated
with the appropriate antibiotic or if the correct duration of antibiotic treatment was
prescribed.
Procedures
The research proposal was shared with the Medical Director, Center Operations
Director, Area Operations Director, Regional Operations Director, the Risk & Regulatory
Committee, and the Legal Team at Concentra, a division of Humana. Verbal agreement
was obtained from all parties and a written research contract was drafted by the legal
department and was signed by the researcher and all necessary parties. Additionally, the
research proposal was submitted to and approved by the Institutional Review Board
(IRB) at Rhode Island College and Humana.
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The researcher completed all data collection after IRB approval and before
December 31, 2014. Charts were selected at random from the storage file room; charts
meeting the inclusion criteria were used to derive the sample. A master list (Appendix A)
paired each medical record number with a corresponding chronological number from one
through seventy-five; only the chronological numbers and not the medical record number
appear on the actual data collection tool. This was done to ensure that the any and all of
the data appearing on the data collection tool had been completely de-identified. The
master list and data collection tool were kept on a password protected thumb drive and
stored in a locked cabinet at the Concentra-Warwick facility. Only the researcher
possessed the key to access the data.
Data Analysis
Basic descriptive statistics were utilized to analyze the antimicrobial prescribing
trends within the clinic as compared to national averages. The ultimate measurement was
percentage of patients for whom antibiotics were overprescribed. Additionally,
correlations between patient demographic data, such as age and insurance status and
prescribing tendencies, were also performed.
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Results
A total of 200 charts were reviewed; 86 were excluded because they did not meet
the inclusion criteria. Another 16 charts were eliminated as the patients were seen
outside of the review timeframe of January 1, 2014 to October 1, 2014. After further
review of the remaining 98 charts, an additional 23 charts were removed due to the
potential confounding variable of multiple diagnoses for which antibiotics could have
been prescribed. Thus, the remaining charts (n=75) were reviewed to identify the
appropriateness of treatment.
The age range of the clients were from 19 to 87 with a mean of 41.7 years. Four
percent (n=3) of the patients were uninsured. None of the charts reviewed contained any
documentation pertaining to a history of COPD.
Fifty-six percent (n=42) of the patients were treated by medical doctors, 31%
(n=23) were treated by nurse practitioners and 13% (n=10) were treated by physician
assistants. Of the 75 charts reviewed, 39% (n=29) of the charts revealed a diagnosis of
bronchitis, 29% (n=22) revealed a diagnosis of upper respiratory infection, 24% (n=18)
revealed a diagnosis of pneumonia; and 8% (n=6) with a diagnosis of cough.
A total of 17 patients were identified as having been prescribed antibiotics
inappropriately; two of the three uninsured patients were included (66.67%). A
breakdown of the prescribing trends specific to each credentialed prescriber group is
illustrated in Table 1.
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Table 1
Prescribing Trends by Prescriber Credential
Prescriber
Credential
MD
NP
PA
Total

# and % of
Patients Treated
42 (56%)
23 (31%)
10 (13%)
75 (100%)

# and % of Patients
Overprescribed
12 (70%)
3 (18%)
2 (12%)
17 (100%)

Overall Percent of
Overprescribing
16%
4%
2.66%
22.66%

As can be seen, MDs exhibited the highest rate of overprescribing and PAs the
lowest. There was nearly a one-in-three chance of obtaining an unnecessary and
unwarranted antibiotic from an MD in this sample. Proportionally speaking, MDs saw
nearly twice as many patients as NPs and more than four times as many as PAs. Next,
rates of overprescribing were further broken down by diagnosis (Table 2).
Table 2
Prescribing Trends According to Diagnosis
Diagnosis
Cough
URI
Bronchitis
Pneumonia
Total

# and % of Patients
Overprescribed
1 (6%)
1 (6%)
15 (88%)
0 (0%)
17 (100%)

Of the 17 patients that received unwarranted antibiotics, none of the patients
exhibited any of the ACCP guideline criteria for treatment. All 17 patients were afebrile,
eupneic, normocardic, and without evidence of consolidation on physical exam. Despite
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normal exams, 53% (n=9) of these 17 patients went on to have chest x-rays, all nine of
which were read as negative.
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Summary and Conclusions
Approximately two million people in the U.S. are infected annually by organisms
that have developed resistance to one or more of the antimicrobials designed to eradicate
them. Roughly 23,000 of those people will succumb to drug-resistant infections; this is
in addition to the tremendous number of lives lost due to conditions complicated by the
infection (CDC, 2013). Nearly 250,000 people each year are hospitalized for Clostridium
difficile infections, with the majority of cases attributed to antibiotic use as a
predisposing factor. It is estimated that at least 14,000 people die each year as a result of
this particular type of infection (CDC, 2013).
Ranking highest among categories of illness for which antibiotics are most
commonly overprescribed is respiratory infections (CDC, 2014a). Each year, roughly
$1.1 billion dollars is spent on the estimated 41 million unnecessary antibiotic
prescriptions for patients experiencing viral respiratory tract infections. This does not
include the excess healthcare costs related to the adverse effects and complications of
unwarranted pharmacotherapy (Fendrick et al., 2003).
Though the issue of antibiotic resistance is a worldwide concern, the already
overburdened US healthcare system finds itself particularly affected by the considerable
amount of avoidable cost. Antibiotic resistant infections, as compared to those easily
treated with antibiotics, necessitate additional or lengthier treatments, longer hospital
stays, more attention from healthcare workers, increased utilization of healthcare dollars
and are associated with greater morbidity and mortality. Though difficult to calculate,
estimates reveal that up to 20 billion dollars annually has been appropriated for excess
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health care costs, with an additional 35 billion dollars in costs to society for lost
productivity of the workforce (Infectious Diseases Society of America, 2010). These
figures become particularly striking when taking into account that nearly 50% of
prescribed antibiotics are unwarranted or ineffectual as prescribed (CDC, 2013).
The inappropriate use of antimicrobials and the evolution of multi-drug resistant
organisms continues to be a significant problem despite acknowledgment of the problem
and familiarity with guidelines. The purpose of this project was to explore current
antimicrobial prescribing trends for respiratory infections at an urgent care facility. The
research question motivating this project was: What are the antimicrobial prescribing
trends for respiratory infections at an urgent care facility as compared to the national
average? The ACE Star Model of Knowledge Transformation (Stevens, 2004) was
utilized to serve as a guide in conducting this research study. The model was primarily
developed to assist when the sheer complexity and volume of knowledge alone becomes
an obstacle when trying to sort through ever-evolving evidence-based practice. It serves
as reassurance that at any time new information can enter in the perpetually revolving
door of information processing, and can do so seamlessly, as this process will never be
linear.
Exceptionally thorough and detailed guidelines have been developed by the
ACCP to assist clinicians with an evidence-based approach to optimal management of
chest infections (Irwin, 2006). While these guidelines serve as a reference tool for
clinicians, they have not been updated since 2006 and are largely subject to interpretation
as patients’ can have wide variability in clinical presentation.
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Perhaps a partial solution to the inherent outdated nature of guidelines, due to
the large consumption of time dedicated to their compiling, would be to impose and
uphold a mandatory proportion of antimicrobial pharmacology continuing education
credits for all prescribing clinicians regardless of credentials. The education campaign
can be spearheaded by the advanced practice registered nurses (APRNs) within the
organizations that partner with the CDC to champion this cause. Organizations such as
the ACCP can utilize their APRN members to transform change and disseminate
pharmacological updates, threat reports, and news of emerging multi-drug resistant
organisms.
While APRNs are capable of functioning using the upstream approach to educate
and reduce the prevalence of inappropriate antimicrobial prescribing, much damage has
already been done and as such APRNs must also function using the downstream
approach as well. That is, APRNs must also be able to deal with the present effects of
years worth of overprescribing. One of the ways in which this can be achieved is by
research, development and innovation on behalf of the pharmaceutical industry.
Unfortunately, antibiotics are relatively inexpensive drugs and consequently of little to no
profit or interest for pharmaceutical companies. Therefore, it is imperative for APRNs to
lobby on a national level on behalf of healthcare, healthcare dollars and in the best
interest of patients.
In this study, the rate of overprescribing at the study site was found to be
approximately 22.66% as compared to the national average of 50% (CDC, 2013). Of the
17 patients that received unwarranted antibiotics, none of the patients exhibited any of the
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ACCP criteria for treatment. All 17 patients were afebrile, eupneic, normocardic, and
without evidence of consolidation on physical exam. Despite normal exams, 53% (n=9)
of these 17 patients went on to have chest x-rays, all nine of which were read as negative.
Despite a low representation within the sample size, it is nevertheless noteworthy that
66% (n=2) of the uninsured patients were included in the total of patients (n=17) treated
with antibiotics despite not meeting any criteria. Given the exceptionally small sample
size correlations cannot be determined, however correlating overprescribing and
insurance status would be an area for further exploration in both quantitative and
qualitative studies to determine if rates of overprescribing to the uninsured are
statistically significant and if so, why?
MDs exhibited the highest rate of overprescribing and PAs the lowest. There was
nearly a one-in-three chance of obtaining an unnecessary and unwarranted antibiotic from
an MD in this sample. Proportionally speaking, MDs saw nearly twice as many patients
as NPs and more than four times as many as PAs and perhaps this could, in part, account
for the higher percentage of overprescribing. Clinicians in this setting faced a unique set
of challenges and barriers to prescribing appropriately. Not only do they experience time
constraints, patient satisfaction and expectation responsibility, prescribing fatigue, and
limited resources, but also on the forefront of these obstacles is the lack of continuity and
follow-up with patients.
Taking into account the retrospective design of the study, the information
obtained from the chart was limited to what was documented and was assumed to be
adequate and accurate. The study was also limited by the small sample size, limited
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examination of variables, including ethnicity and gender, and inability to include date
of service as a potentially confounding variable, as time year/season causes fluctuations
in antimicrobial prescribing (Sun et al, 2012). Additionally, the urgent care setting is
faced with inherent limitations such as an implausibility to perform sputum cultures due
to time, follow-up and equipment.
Integrating an APRN to the study site’s newly formed infection control panel
would assist in the identification and prevention of problem areas, review and critique of
current literature, development of resources and staff support tools, as well as
implementation of changes in practice in accordance with clinical practice guidelines to
enhance patient outcomes. Perhaps with further exploration and careful assessment and
planning, reduction of rates of overprescribing could be achieved within this facility
through increased clinician support and the implementation of prescription monitoring
such as antimicrobial stewardship.
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Recommendations and Implications for Advanced Practice
While healthcare providers are nearing maximum potential in the ability to treat
infectious diseases, organisms are evolving faster than the antibiotics manufactured to
treat them. While the number of lives saved by antibiotics is undoubtedly staggering, so
also is the steadily increasing number of lives lost due to the inefficacy, in part related to
overuse of those same drugs. Decades of poor prescribing practices have paved the way
for the rapid upsurge of drug sensitivities, allergic reactions, resistant infections and
potentially fatal cases of diarrhea (CDC, 2014a).
While explaining the ins and outs of antimicrobial resistance may not be the go-to
lecture for patients inquiring as to the whereabouts of their antibiotic, the current
recommendation is to stand firm in the judicious selection of antibiotics and only treat
when appropriate. The emphasis must now be on prevention of dangerous and
potentially fatal sequelae from unwarranted antibiotic prescribing, whatever the reason
for overprescribing may be. In a largely litigious society, defending non-action will
always be more challenging than defending action because of the connotation of neglect
or withholding. As such, judicious use of antibiotics will be a huge hurdle to overcome.
Defensive medicine and other means of overprescribing will continue until and unless
there is identifiable leadership at all levels of practice willing to establish change.
Change must occur not only at organizational levels, but at local, state, and federal levels
and also protect the clinicians whom are prescribing in the best interest of the patients.
Part of this change must incorporate much needed education for clinicians
entering the field regarding the detrimental downstream effects of overprescribing.
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Additionally, education and pharmacological updates must be readily available for
seasoned prescribers. This education could be effectively incorporated into
pharmacological continuing medical education requirements, as information surrounding
antimicrobial prescribing is ever-evolving due to the nature of prescribing trends and
bacterial evolution.
Calculating the current prescribing trends and overprescribing rates is the first
step in acknowledging the issue within this particular setting. Much more progress needs
to be made to address methods and strategies for resolution including the adaptation of a
modified antimicrobial stewardship applicable to ambulatory/urgent care settings. Once
rates of overprescribing are identified, perhaps a subject for future exploration could be
examining opinions from prescribers as to why it continues. Additionally, correlations
between overprescribing and age, gender, ethnicity, and insurance status could be
explored.
Despite the urgency for solutions to the ever-growing issue of bacterial resistance,
clinical research is still severely lacking with respect to randomized controlled trials.
This dearth of research is attributed to the severity of illness in the effected population, as
well as unwillingness of the pharmaceutical industry to fund such studies until new
antibiotics, capable of eliminating multi-drug resistant organisms, have been developed
(Infectious Diseases Society of America, 2010). Much of the stagnation with respect to
antimicrobial resistance research is due to the lack of appropriation of funding and
whether those funds should be allocated toward improving the old antibiotics or
developing new ones. This lack of progress with evidence-based research serves to
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explain why current research articles and principles often cite older information and
guidelines. Thus, it is important that the US FDA demand and expect studies of patients
at high risk for developing multi-drug resistant infections (Paterson & Rogers, 2010).
Additionally, APRNs can partner with the FDA and legislators to push forward
for legislation and policy in an attempt to prevent the perpetuation of the bacterial
resistance cycle. For example, legislation was introduced March 2, 2015 by US Senators
Susan Collins (R-Maine), Kirsten Gillibrand (D-N.Y.) and Elizabeth Warren (D-Mass.)
(Breslow, 2015). The bill seeks to close a gap in guidelines set forth by the FDA in 2013
for drug makers to end the use of antibiotics in farm animals as a means for gaining
weight (Breslow, 2015). The drug maker must end the use of the antibiotic unless they
can prove that the use of the antibiotic in the farm animal will not harm human health
(Breslow, 2015). The bill also aims to establish limits on how long medications can be
used for preventing or controlling disease. The FDA approximates that 107 antibiotics
either have no limit on how long they can be used or are labeled for continuous use
(Breslow, 2015). Subsequently, the fear is that the longer an animal remains on an
antibiotic the higher the risk for the development of a multi-drug resistant organism.
APRNs represent a powerful catalytic agent and when partnered with legislators
can instigate immense change. APRNs have the unique opportunity to partner with these
three US Senators to expand the authority of the FDA to discontinue certain antibiotics
from use. This could very well be the beginning of the cycle of change. Expanded FDA
authority may start with antibiotic use in animals, but eventually extend to consumption
in humans. It could lead to randomized controlled trials; biopharmaceutical innovation;
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antimicrobial stewardship; policy on the national level; and mandated pharmacological
update continuing medical education (CME). The rise against bacterial resistance is
beginning and APRNs need to be there every step of the way.
In striving to hold clinician prescribers accountable, an interesting subject for
further evidence based research and practice would be examining the amount of time it
takes for antibiotic therapy to be changed from broad spectrum to targeted therapy after
clinicians review culture results. Research of this type could potentially result in a
mandatory medication reconciliation after initial review and verification of any and all
culture and sensitivities. Not only can APRNs champion the fight against
overprescribing and multi-drug resistant organisms within their own organization and
amongst their peers and patients, they can help push for new innovation by continually
producing quality evidence based research such as the example above.
Resistance begins in the community and impacts resistance in the inpatient
setting. In sum, a community’s prescribing trends, especially shifting to broader
spectrums of coverage in lieu of appropriately targeted therapies, impacts the level of
resistance in that community. It then potentiates sicker people, with more resistant
pathogens, who must seek care in hospital settings, thereby increasing prevalence of
resistant organisms (Walker, 2012). In order to prevent this cycle from continuing, it is
necessary to address factors contributing to inappropriate prescribing, non-adherence to
prescribing guidelines and to meet these barriers with appropriate and well thought out
strategies for resolution.
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Regardless of how the resolution to this worldwide problem will come about, it
will not happen without multi-disciplinary cooperation. APRNs are in a unique position
to be able to act as leaders and educators on both sides of prescribing. APRNs must take
the time to educate their patients, their patients’ families, co-workers, peers, and anyone
who will listen about why antibiotics aren’t always the answer. Hopefully educating the
masses will be more contagious than the multi-drug resistant pathogens that may one day
infect them.
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